ITGB3 and non-small cell lung carcinoma: We performed dual immunohistochemistry (IHC) and flow cytometric CD61 protein analyses on samples from a cohort of patients with non-small cell lung cancer (NSCLC) obtained from the Oxford Radcliffe Biobank (ORB; Extended Data Figs. 2 and 3a).